Impact of Anti-inflammatory and Antibiotic Therapy on the Emergence of Peri-tonsillar Abscess

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00954031

Acronym

APA

Enrollment

711

Registered

2009-08-06

Start date

2009-03-31

Completion date

2012-07-31

Last updated

2013-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abscess, Peritonsillar

Brief summary

Analyze in children and adults, risk factors in the onset of the APA. The main hypothesis focuses on the use of anti-inflammatory in the context of pharyngitis or sore throat before the symptoms of ABS. Secondary objectives: 1. \- Analyze the implementation of a rapid diagnostic test and its result on the occurrence of an ABS 2. \- Measure the frequency of prescription and describe the reasons for not prescribing an antibiotic for patients who consulted for a sore throat and having developed a PLA 3. \- Describe the microbial flora could puncture of patients hospitalized for APA

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* clinical existence of a PLA (phlegmon), validated by a senior ENT, usually (but not necessarily) following a request by an emergency. The visible appearance to the merits throat must justify puncture. Cases will be included whether or not they had consulted for a sore throat in the 10 days preceding the date of diagnosis

Exclusion criteria

* Neoplastic disease of the throat, scalable Hematologic with tonsillar localization History of tonsillectomy

Design outcomes

Primary

Measure	Time frame
The principal judgement criterion of the study is the positive diagnosis of an APA. The explanatory variables to meet the main objective is the drug exposure (anti-inflammatory)	2,5 years

Secondary

Measure	Time frame
The explanatory variables to meet the secondary objectives are: - The creation of a TDR - The prescription of antibiotics - The diagnosis of angina Strep Group A - The identification of a group A streptococcus in t	2,5 years

Countries

France

Outcome results